NT 13 (TPPT) is a tetrapeptide having the amino acid sequence L-threonyl-L-prolyl-L-prolyl-L-threonine amide. NT 13 is a partial N-methyl-D-aspartate receptor (NMDAR) agonist used in the study of depression, anxiety, and other related diseases.
NT 13 is a synthetic peptide compound that has garnered significant interest within the fields of neurobiology and peptide biochemistry due to its unique sequence and functional attributes. As a member of the neurotensin-related peptide family, it serves as a valuable molecular tool for probing neuropeptide signaling pathways and receptor-ligand interactions. Its defined structure and stability make it highly suitable for controlled experimental studies, facilitating the investigation of complex neurochemical processes and peptide-mediated cellular responses. The compound's versatility extends to a range of biochemical and pharmacological research applications where precise modulation of peptide pathways is essential.
Receptor Binding Studies: NT 13 is frequently employed in receptor binding assays to characterize the affinity and specificity of neurotensin receptors and related G protein-coupled receptors. By serving as a model ligand, it enables researchers to dissect receptor-ligand dynamics, evaluate competitive binding interactions, and elucidate the molecular determinants governing receptor activation. These studies are crucial for mapping receptor pharmacology and for identifying novel modulators or antagonists within the neuropeptide signaling landscape.
Signal Transduction Research: As a functional analog of endogenous neurotensin peptides, NT 13 facilitates the examination of downstream signaling cascades triggered upon receptor engagement. Researchers utilize it to activate or inhibit specific intracellular pathways, such as those involving second messenger systems or kinase activation. This application supports the detailed analysis of cellular responses to peptide stimulation, providing insight into the mechanisms underlying neural communication, synaptic plasticity, and peptide-mediated modulation of neuronal activity.
Peptide Structure-Activity Relationship (SAR) Analysis: The defined sequence of NT 13 makes it an ideal candidate for structure-activity relationship studies. By systematically modifying its amino acid residues or comparing its activity to related analogs, investigators can identify key structural motifs responsible for biological function. These SAR studies inform the rational design of novel peptide ligands with enhanced selectivity or altered functional profiles, advancing both basic science and applied peptide engineering efforts.
Peptide Stability and Metabolism Investigations: NT 13 is also utilized in studies focused on peptide stability, degradation, and metabolic processing. Researchers assess its susceptibility to enzymatic cleavage in various biological matrices, providing data on peptide half-life and metabolic fate. Such investigations are vital for understanding the in vivo persistence of peptide ligands and for optimizing peptide-based tool compounds intended for experimental use in complex biological systems.
Neurochemical Pathway Mapping: In neurobiology and neurotransmitter research, NT 13 serves as a probe for mapping peptide-mediated signaling pathways in both in vitro and ex vivo systems. By applying the compound to neuronal cultures or tissue preparations, scientists can monitor changes in neurotransmitter release, receptor expression, or electrophysiological properties. These experiments contribute to a deeper understanding of the roles neuropeptides play in modulating synaptic transmission and neural circuit dynamics, supporting the development of new research models in neuropharmacology and neurochemistry.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More